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Epidermolysis bullosa (EB) is a group of autosomal dominant and recessive blistering skin diseases in which
pathogenic mutations have been reported in 13 different genes encoding structural proteins involved in
keratinocyte integrity, as well as cell–matrix or cell–cell adhesion. We now report an inherited skin fragility
disorder with a homozygous nonsense mutation in the dystonin gene (DST) that encodes the coiled-coil
domain of the epithelial isoform of bullous pemphigoid antigen 1, BPAG1-e (also known as BP230). The
mutation, p.Gln1124X, leads to the loss of hemidesmosomal inner plaques and a complete absence of skin
immunostaining for BPAG1-e, as well as reduced labeling for plectin, the b4 integrin subunit, and for type XVII
collagen. The 38-year-old affected individual has lifelong generalized trauma-induced spontaneous blisters and
erosions, particularly around the ankles. In addition, he experiences episodic numbness in his limbs, which
started at the age of 37 years. These neurological symptoms may also be due to DST gene mutation, although he
has a concomitant diagnosis of CADASIL (cerebral arteriopathy, autosomal dominant, with subcortical infarcts
and leukoencephalopathy), a cerebral small-vessel arteriopathy, which thus complicates the genotype–pheno-
type interpretation. With regard to skin blistering, the clinicopathological findings expand the molecular basis
of EB by identifying BPAG1-e pathology in a new form of autosomal recessive EB simplex.
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INTRODUCTION
The group of inherited blistering skin diseases, known as
epidermolysis bullosa (EB), represents a diverse collection of
autosomal dominant and autosomal recessive disorders with
varying skin, mucous membrane, and extracutaneous
abnormalities (Fine et al., 2008; Fine and Mellerio,
2009a, b). Originally classified into three main subtypes,
namely EB simplex, junctional EB, and dystrophic EB, on
the basis of the level of tissue cleavage at or close to
the dermal–epidermal junction (DEJ), the latest classification
of EB has been expanded to include other cell–cell or
cell–matrix adhesion disorders (Fine et al., 2008). Thus, the
term ‘‘EB’’ now encompasses inherited disorders of hemi-
desmosome attachment complexes, keratin intermediate
filaments, focal adhesions, and desmosome cell junctions,
and involves pathogenic mutations in 13 genes encoding
11 different structural proteins (Fine et al., 2008).
One skin protein that has not yet been implicated in the
pathogenesis of EB, however, is bullous pemphigoid antigen
1 (BPAG1-e) (also known as BP230), a key component of
hemidesmosomes and a member of the plakin family with
cytoskeletal linker properties (Borradori and Sonnenberg,
1999; Leung et al., 2001a; Litjens et al., 2006; Sonnenberg
and Liem, 2007). BPAG1-e is encoded for by the dystonin
(DST) gene, the alternative splicing of which may give rise to
& 2010 The Society for Investigative Dermatology www.jidonline.org 1551
ORIGINAL ARTICLE
Received 31 October 2009; revised 13 December 2009; accepted 3 January
2010; published online 18 February 2010
1St John’s Institute of Dermatology, The Guy’s and St Thomas’ NHS
Foundation Trust, St Thomas’ Hospital, London, UK; 2Division of Genetics
and Molecular Medicine, King’s College London, Guy’s Hospital, London,
UK; 3The Robin Eady National Diagnostic Epidermolysis Bullosa Laboratory,
GSTS Pathology, St Thomas’ Hospital, London, UK; 4Department of Clinical
Neuroscience, St George’s University of London, London, UK; 5145 Harley
Street, London, UK; 6Division of Biological Science, Graduate School of
Science, Nagoya University, Nagoya, Japan and 7Department of
Dermatology, Kurume University School of Medicine, Kurume, Fukuoka,
Japan
Correspondence: John A. McGrath, Dermatology Research Laboratories, 9th
Floor, Tower Wing, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK.
E-mail: john.mcgrath@kcl.ac.uk
Abbreviations: BPAG1, bullous pemphigoid antigen 1; CADASIL, cerebral
arteriopathy, autosomal dominant, with subcortical infarcts and
leukoencephalopathy; DEJ, dermal–epidermal junction; DST, dystonin;
EB, epidermolysis bullosa
multiple tissue isoforms with variable expression in the skin,
neurons, muscles, and the central nervous system (Leung
et al., 2001b; Jefferson et al., 2006; Young and Kothary,
2007, 2009). The main isoform expressed in the central
nervous system is BPAG1-a, although a further neural variant,
BPAG1-n, may also exist; whether BPAG1-n is expressed
in vivo, however, is uncertain (Leung et al., 2001b). In
muscle, the main isoform is BPAG1-b. In the skin, there is
a predominance of BPAG1-e, but some BPAG1-a (and
perhaps BPAG1-n) may also be present (Sonnenberg and
Liem, 2007). Details of these DST splice variants and their
functional subdomains are illustrated in Supplementary
Figure S1 online.
Mutations in the mouse Dst gene have previously been
shown to cause sensory neuron degeneration and skin
fragility (Brown et al., 1995; Guo et al., 1995; Pool et al.,
2005; Goryunov et al., 2007), but no humanDST gene patho-
logy has been reported, apart from a t(6;15)(p11.2;p12)
translocation in a 4-year-old girl that resulted in encephalo-
pathy, severe motor and mental retardation, and delayed
visual maturation (Giorda et al., 2004). In that case, the
chromosome 6 break point was between the BPAG1-a and
BPAG1-b isoforms, but no abnormality of BPAG1-e was
evident.
We now report details of an individual with a naturally
occurring homozygous nonsense mutation in part of the DST
gene that encodes for the coiled-coil domain, which is
exclusively expressed in BPAG1-e and BPAG1-n isoforms.
RESULTS
Clinical features of skin blistering and neurological symptoms
The affected individual was a 38-year-old Kuwaiti man born
to distantly related parents. He was the second of five siblings
and the only one with a history of blisters. His two children
had no skin symptoms and there was no family history of
skin fragility or blistering. The patient had experienced
lifelong trauma-induced spontaneous blisters and erosions,
particularly around his ankles and feet (Figure 1a), although
the face, trunk, and more proximal limbs were also affected.
Blisters and erosions healed without delay, scarring, or milia
formation. Blistering was associated with skin peeling and
occasional hemorrhage, as well as hypopigmentation and
some postinflammatory hyperpigmentation. Nail dystrophy
of all toenails was present, particularly affecting the
great toes. Hair growth was normal. There was no history
of mucosal blistering, although moderate dental caries and
reactive gingival inflammation were evident. The patient
reported no gastrointestinal or urological symptoms.
In addition to skin blistering, the patient had a few years’
history of neurological symptoms, including two episodes
of collapse, recurrent bilateral headaches, and transient
episodes of left arm numbness and weakness lasting a few
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Figure 1. Ultrastructural abnormalities of hemidesmosomal inner plaques provide clues to the pathology of a new inherited skin fragility disorder.
(a) Clinically, there is a blister measuring 2.5 1.5 cm on the right heel, as well as an area of earlier blistering on the right sole showing reepithelialization,
some scale, minor hemorrhage, but no scarring. Other features include postinflammatory hyperpigmentation on the dorsal aspect of the right foot close to
the great and second toes at the site of the old blistering, and dystrophy of the right great toe nail after previous trauma (no fungus was present on microscopy
and culture). (b) Transmission electron microscopy of the dermal–epidermal junction (DEJ) in patient skin shows keratin intermediate filaments (KIFs) and
hemidesmosomal outer plaques (HD OP), but a lack of hemidesmosomal inner plaques (HD IP). In contrast, transmission electron microscopy of the
DEJ in normal control skin reveals that HDs have clearly defined HD IPs and HD OPs (bar¼ 100nm).
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seconds at a time. There was no history of stroke or depres-
sion. Both parents were deceased; his mother died at the
age of 56 years after multiple strokes. He had two sisters and
three brothers, one of whom had been given a diagnosis
of ‘‘multiple sclerosis’’ after a number of neurological events
that were consistent with minor strokes. Magnetic resonance
brain imaging in our patient showed scattered white
matter hyperintensities, but no involvement of the anterior
temporal pole and the external capsule. Normal investiga-
tions included the following: intracranial and extracranial
magnetic resonance angiography, cerebrospinal fluid exami-
nation including oligoclonal bands, visual brainstem, and
somatosensory evoked potentials. On the basis of family
history, abnormal magnetic resonance imaging, and neuro-
logical symptoms, he had a concomitant diagnosis of auto-
somal dominant cerebral small-vessel arteriopathy CADASIL
(cerebral arteriopathy, autosomal dominant, with sub-
cortical infarcts and leukoencephalopathy; MIM125310)
(Joutel et al., 1996).
Thus, our patient had a history of skin blistering resem-
bling a form of EB; his mother, brother, and he had neuro-
logical histories consistent with CADASIL.
Transmission electron microscopy of the DEJ reveals
abnormal hemidesmosomal inner plaques
The primary clue to the molecular pathology responsible for
skin fragility came from ultrastructural observations and a
candidate gene approach. Although no blisters or microsplits
were noted at or close to the DEJ, discrete abnormalities of
hemidesmosomes were evident. There were no differences
from control skin in the overall number of hemidesmosomes,
but the morphology of individual hemidesmosomes was
abnormal. Notably, the inner plaques were poorly formed
or completely absent, leading to a lucent zone between
keratin filaments and the outer hemidesmosomal plaques
(Figure 1b). The keratin filaments extended to where the
inner plaques should be, but did not seem to associate
with any plasma membrane attachment structure. The outer
hemidesmosomal plaques, however, showed no gross
abnormalities. Similarly, sub-basal dense plates, anchoring
filaments, the lamina lucida, the lamina densa, and anchor-
ing fibrils, were all within normal limits. Thus, transmission
electron microscopy provided the specific ultrastructural
clue that an abnormality of a gene encoding a structural
component of the hemidesmosomal inner plaque might
underlie the skin fragility in this patient. We also searched
for granular osmiophilic material around vascular smooth
muscle in the deep dermis, as this has been noted
as a specific ultrastructural feature of CADASIL (Ishiko
et al., 2005), but did not identify pathognomonic changes.
Immunofluorescence microscopy and immunoblotting show
an absence of BPAG1-e expression in skin/keratinocytes
Immunolabeling of the DEJ in the patient’s skin showed
reduced-intensity staining for several hemidesmosome-
associated proteins. Notably, there was a complete absence
of immunoreactvity using a BPAG1-e-specific antibody
(BPC319, directed against the carboxyl terminal domain
of BPAG1-e, Okumura et al., 2002) compared with bright,
linear labeling at the DEJ in control skin (Figure 2a). Immuno-
blotting using keratinocyte extracts and an additional
BPAG1-e antibody (5E, directed against the carboxyl
terminal domain of BPAG1-e, Hashimoto et al., 1993)
showed a complete absence of BPAG1-e in the patient’s
cells (Figure 2b). Immunostaining of skin sections from the
patient also revealed markedly reduced labeling for the
b4 integrin subunit at the DEJ, moderately reduced plectin
immunoreactivity, and slightly diminished type XVII
collagen immunolabeling (Supplementary Figure S2 online).
No differences compared with control skin were noted for
the a6 integrin subunit, as well as for keratin 14, laminin-332,
collagen IV, or collagen VII (Supplementary Figure S2
online).
DST mutation screening identifies a homozygous nonsense
mutation in the coiled-coil domain, present in BPAG1-e
and BPAG1-n isoforms
Sequencing of the patient’s genomic DNA identified a
homozygous C4T transition (c.3478C4T; GenBank
NM_001723.4) that converts glutamine to a stop codon,
designated p.Gln1124X (Figure 2c). This mutation occurs
within the coiled-coil domain, a region that is not present in
BPAG1-a or BPAG1-b (Supplementary Figure S1 online). This
mutation was not identified in screening 200 ethnically
matched control chromosomes. Sequencing of the PLEC1
gene encoding plectin and the ITGB4 gene encoding the b4
integrin subunit was also performed, but no pathogenic
mutations were identified.
The nonsense mutation in DST does not lead to a major
reduction in mRNA levels relevant to the BPAG1-e isoform
The mutation, p.Gln1124X, occurs in the penultimate exon
of the transcript encoding BPAG1-e (exon 23 of 24). We
assessed the consequences of the mutation in gene expres-
sion by performing real-time reverse transcriptase-PCR using
RNA extracted from the patient and control skin and creating
different primer pairs upstream of the mutation, spanning the
mutation in the coiled-coil domain, and in the 30 untranslated
region (Figure 2d). Gene expression levels in the patient were
reduced by B25% in the 30 untranslated region. In contrast,
there was only a very slight reduction (o3%) for the other
primer pairs.
NOTCH3 mutation screening identifies a heterozygous
cysteine substitution consistent with a concomitant diagnosis
of CADASIL
Sequencing of the patient’s genomic DNA identified a
heterozygous G4C transversion (c.1790G4C; GenBank
U97669) in exon 11 of NOTCH3 that converts cysteine to
serine, designated p.Cys597Ser (not illustrated). This muta-
tion is typical of CADASIL, in which mutations result in
unpairing of a cysteine–cysteine bond in one of the epidermal
growth factor-like repeats present in the extracellular portion
of the transmembranous NOTCH3 protein (Joutel et al.,
1997). This mutation was not detected in screening 200
ethnically matched control chromosomes.
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DISCUSSION
DST mutation and inherited skin fragility
Delineation of a homozygous nonsense mutation in DST
expands the number of basement membrane genes and
proteins implicated in the pathogenesis of the different forms
of EB, and also highlights the importance of hemidesmo-
somes in maintaining epidermal integrity (Supplementary
Figure S3 online). Hemidesmosomes are intricate multi-
protein adhesion complexes that provide a stable attachment
between the basement membrane and the stratified (and
other) epithelia (Litjens et al., 2006). In the skin, hemidesmo-
somes are composed of BPAG1-e, plectin, a6b4 integrin,
tetraspanin CD151, and type XVII collagen. Together, these
proteins form an intricate network that provides a structural
bridge extending from keratin intermediate filaments in basal
keratinocytes to the collagen fibers within the papillary
dermis (Koster et al., 2003). Both BPAG1-e and plectin bind
to keratin filaments. For BPAG1-e, the binding to keratin
occurs through its carboxyl domain, whereas its amino
terminus binds to the cytoplasmic domain of type XVII
collagen (Borradori and Sonnenberg, 1999; Hopkinson and
Jones, 2000; Fontao et al., 2003), as well as to b4 integrin
and erbin (Favre et al., 2001). Plectin also binds to b4 integrin
(de Pereda et al., 2009), and b4 integrin binds to erbin
(Favre et al., 2001).
The homozygous nonsense mutation in our patient led to a
loss of BPAG1-e protein expression at the DEJ and in
keratinocytes, as determined by immunofluorescence micro-
scopy and western blotting using two antibodies directed
against the carboxyl terminus of BPAG1-e. Nonsense
mutations typically lead to mRNA decay, except when
located in the last exon or the distal part of the penultimate
exon (Mu¨hlemann et al., 2008; Neu-Yilik and Kulozik,
2008; Silva and Roma˜o, 2009). The mutation p.Gln1124X
is located within the proximal part of the penultimate
exon but does not seem to lead to substantial mRNA
decay. Nevertheless, immunostaining of the patient’s skin
sections showed reduced labeling for several other hemi-
desmosomal components that directly or indirectly associate
with the amino and carboxyl domains of BPAG1-e. It is
noteworthy that there was reduced protein labeling for the
b4 integrin subunit, as well as for plectin and type XVII
collagen. The most marked reduction in labeling was for
b4 integrin, which is of interest, given recent data showing
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Figure 2. Loss of BPAG1-e protein expression due to a homozygous nonsense mutation in the DST gene. (a) Immunofluorescence microscopy using an
antibody that recognizes the carboxyl terminal region of bullous pemphigoid antigen 1 (BPAG1)-e (clone BPC319) reveals completely undetectable
immunostaining in patient skin in contrast to linear labeling at the dermal–epidermal junction (DEJ) in normal control skin. (Bar¼ 50 mm). (b) Immunoblotting
using extracts from cultured keratinocytes shows a complete absence of BPAG1-e in patient material compared with control (clone 5E, carboxyl terminal
region of BPAG1-e). (c) DNA sequencing reveals a homozygous nonsense mutation partly of the DST gene coding for the coiled-coil domain of BPAG1-e
(and BPAG1-n). In patient genomic DNA, there is a homozygous C4T transition (c.3478C4T, GenBank NM_001723.4) that converts glutamine to a stop
codon (p.Gln1124X) that is not present in wild-type sequencing. (d) Real-time reverse transcriptase (RT)-PCR using primer sets upstream from the mutation
(PP1) and spanning the mutation in the coiled-coil domain (PP2) shows that the nonsense mutation does not lead to mRNA decay. For the primer sited in
the 30 untranslated region (UTR) (PP3), patient mRNA is reduced by only B25%, consistent with a nonsense mutation in the penultimate exon of a gene
transcript not triggering substantial mRNA decay. The schematic illustrates how RT-PCR primers relate to the domains of BPAG1-e. This schematic also
illustrates the epitopes of BPAG1-e corresponding to the antibodies used for the data shown in panels a and b.
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that BPAG1-e maintains keratinocyte polarity through b4
integrin-mediated modulation of Rac1 and cofilin activation
(Hamill et al., 2009).
Ultrastructurally, the DST mutation was associated
with loss of the hemidesmosomal inner plaque, but not with
gross changes in the size or number of hemidesmosomal
outer plaques, sub-basal dense plates, anchoring filaments, or
anchoring fibrils. Keratin filaments were still seen in close
apposition to the missing inner plaques, although no clear
attachment structures for the filaments were evident.
Although none of the skin biopsy samples obtained from
the patient provided histological evidence for the level
of blister formation, it is highly likely that cleavage occurred
through the level of the missing inner hemidesmosomal
plaques, and thus the subtype of skin fragility is probably
best classified as an autosomal recessive form of EB simplex.
Compared with other forms of autosomal recessive EB
simplex, the severity of skin blistering in our patient was
relatively mild, indicating a comparatively minor role
in maintaining hemidesmosomal integrity for BPAG1-e
compared with other hemidesmosome-associated proteins.
DST mutation and clinical neuropathology
In our patient, the clinical features also included some neuro-
logical abnormalities, including headaches and parasthesiae.
A key question is whether these symptoms and signs are due
to his DST gene pathology or due to a separate disorder.
In support of the latter, screening of the NOTCH3 gene
identified a heterozygous missense mutation that was typical
of CADASIL, an autosomal dominant small-vessel arterio-
pathy. In this disorder, vascular changes can be seen in the
small arteries throughout the body, but clinical features are
limited to the central nervous system. These include early-
onset lacunar stroke, migraine usually with aura, depression,
and early-onset vascular dementia. Our patient was reviewed
in a UK National CADASIL clinic, however, and it was
believed that these neurological symptoms were not typical
of CADASIL symptomotology, suggesting perhaps that DST
gene pathology might also be a contributing factor.
There are a number of publications linking abnormalities in
the DST gene and BPAG1-e protein to human neurological
abnormalities. Notably, there is an epidemiological association
between patients with the subepidermal blistering disease,
bullous pemphigoid, and an increased incidence of multiple
sclerosis and also Parkinson’s disease (Stinco et al., 2005),
as well as epilepsy, dementia, and stroke (Foureur et al.,
2001, 2006). Moreover, autoantibodies to BPAG1-e have been
associated with various neurological disorders (Li et al., 2009),
and have been identified in the cerebrospinal fluid of some
individuals with multiple sclerosis (Lafitte et al., 2005). TheDST
mutation in our patient is also expected to disrupt BPAG1-n,
although the potential significance of this is unknown, given
that other studies have failed to demonstrate significant tissue
expression of this isoform (Leung et al., 2001b).
Whether our patient’s neurological features are the
consequence of either DST or NOTCH3 gene pathology or
from another cause is still uncertain. To the best of our
knowledge, pathogenic mutations in DST have not been
reported previously, and therefore the future identification of
other individuals with additional mutations in this gene will
be necessary to clarify genotype–phenotype correlation. For
now, delineation of a homozygous loss-of-function mutation
in the DST gene expands the molecular basis of inherited skin
blistering and demonstrates the particular in vivo role of
BPAG1-e in the structural organization of hemidesmosomes
at the cutaneous basement membrane zone.
MATERIALS AND METHODS
Patient and biological samples
The patient provided written and informed consent according to a
protocol approved by the St Thomas’ Hospital Ethics Committee
(molecular basis of inherited skin disease: 07/H0802/104). Blood and
skin samples (ellipse of skin taken under local anesthesia using 1%
lignocaine) were obtained in adherence to the Helsinki guidelines.
The skin sampled was noninflamed, nonlesional skin, as, at the time
of examination, the patient had no fresh blisters (i.e.,o24hours old).
Transmission electron microscopy
Skin biopsy specimens were cut into small pieces (of o1mm3) and
fixed in half-strength Karnovsky fixative for 4 hours at room
temperature. After washing in 0.1 M phosphate buffer (pH 7.4), the
samples were immersed in 1.3% aqueous osmium tetroxide (TAAB
Laboratories, Berkshire, UK) for 2 hours, followed by incubation in
2% uranyl acetate (Bio-Rad, Hertfordshire, UK), and dehydrated in a
graded ethanol series, and then embedded in epoxy resin via
propylene oxide (TAAB Laboratories). Ultra-thin sections were
stained with uranyl acetate and lead citrate and examined in a
Philips CM10 transmission electron microscope (Philips, Eindhoven,
The Netherlands).
Immunofluorescence microscopy
Skin sections measuring 5mm were air-dried and initially blocked
with diluted normal goat serum (Sigma-Aldrich, Dorset, UK), and
then incubated with the following antibodies diluted in phosphate-
buffered saline with 30% w/v bovine serum albumin (Sigma-Aldrich)
where stated: clone BPC319 (BPAG1-e, derived from mice
immunized with a recombinant human 361 amino-acid peptide
within the carboxyl domain; Okumura et al., 2002), used neat
(source K. Owaribe); clone HD1-121 (plectin), 1:40 dilution
(K. Owaribe); clones 450-9D (b4 integrin subunit) and GoH3
(a6 integrin subunit), both 1:250 dilutions (AbD Serotec, Oxford,
UK); clone mAb-123 (collagen XVII), 1:50 dilution (a gift from
M.P. Marinkovich, Stanford, Palo Alto, CA, USA); clone LL002
(keratin 14), 1:1,000 dilution (AbD Serotec); GB3 (laminin-332),
1:300 dilution (http://Immunologicalsdirect.com); clone LH7.2
(collagen VII), 1:1,000 dilution (Sigma-Aldrich, Poole, UK); clone
COL94 (collagen IV), 1:500 dilution (Sigma-Aldrich). After washing
in phosphate-buffered saline, slides were labeled with fluorescein
isothiocyanate secondary antibodies (Invitrogen, Paisley, UK).
Negative controls omitting the primary antibody were performed
for each set of labeling experiments. All sections were photographed
using the same camera and identical exposure times (3 seconds).
DNA sequencing
After obtaining informed consent, genomic DNA was extracted
from a peripheral blood sample obtained from the affected
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individual. For sequencing, DNA was amplified with primers sited in
introns flanking individual exons of the DST gene (Supplementary
Tables 1 and 2 online) and the NOTCH3 gene (for further details, see
Markus et al., 2002). For PCR amplification, 20 ng genomic DNA
was used as a template in an amplification buffer containing
6.25 pmol of primers, 5mmol of each trinucleotide phosphate, and
0.625Units Taq polymerase (Qiagen, Warrington, UK) in a total
volume of 25 ml in a GeneAmp PCR system 9700 thermal cycler
(Applied Biosystems, Crawley, UK). The amplification conditions
were 94 1C for 5minutes, followed by 40 cycles of 94 1C for
30 seconds, 60 1C for 30 seconds, and 72 1C for 45 seconds. Aliquots
(5ml) of PCR products were analyzed by electrophoresis using 3%
agarose gel. PCR products were then purified using a QIAquick
PCR Purification Kit (Qiagen) and sequenced directly in an ABI 3130
genetic analyzer (Applied Biosystems).
Western blotting
Primary keratinocyte cultures were established as described pre-
viously (Mee et al., 2000), and maintained in a defined keratino-
cyte growth medium (EpiLife, Invitrogen, Renfrew, UK) for three
passages. Cellular lysates were prepared from confluent 75 cm2
flasks through addition of 1ml preheated lysis buffer (100mM Tris-Cl
(pH 6.8), 4% SDS, 20% glycerol, 0.1% bromophenol blue, 5%
b-mercaptoethanol), followed by shearing and clarification. Lysates
(12 ml) were separated by denaturing SDS-PAGE using either 5%
(BPAG1-e) or 7.5% (b-actin) gels, alongside 5 ml biotinylated
markers (Precision Plus Protein WesternC Standards, Bio-Rad,
Hemel Hempsted, UK). After transfer to nitrocellulose membranes
(Protran BA 85, Whatman, Maidstone, UK), samples were blocked
(1M glycine, 1% ovalbumin, 5% dry skimmed milk, 5% fetal calf
serum) for 1 hour at room temperature and probed overnight with
either human anti-human BPAG1-e monoclonal antibody (5E, batch
1,748, 1:25 dilution, directed against a 114 amino-acid epitope
within the carboxyl domain, source T. Hashimoto) (Hashimoto et al.,
1993) or rabbit anti-human b-actin polyclonal antibody (ab8227,
Abcam, Cambridge, UK; 1:2,500 dilution) at 4 1C. Detection was
accomplished using horseradish peroxidase-conjugated goat
anti-rabbit (sc-2054) or goat anti-human (sc-2453) IgG antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:3,000 dilution)
for 1 hour at room temperature and visualization was achieved
using the Amersham ECL Plus Western Blotting Detection System
(GE Healthcare, Slough, UK) and autoradiography.
Real-time reverse transcriptase-PCR
Total RNA obtained from patient and normal control skin was
extracted using an RNeasy Fibrous Tissue Mini Kit (Qiagen). In all,
0.5 mg of total RNA was used for each 50ml cDNA synthesis reaction
with SuperScript III Reverse Transcriptase (Invitrogen), followed by
ribonuclease H (Invitrogen) treatment, according to the manu-
facturer’s protocol. Three sets of PCR primers were generated (PP1,
PP2, and PP3, positions illustrated in Figure 2d). PP1 is sited
upstream from the mutation (forward primer 50-AAACGCCGAAGA
ATGCAG-30 nucleotides 3,283–3,300; reverse primer 50-AATATGC
CCCATGTTCAGAAG-30 nucleotides 3,466–3,446; PCR product size
184 bp; GenBank NM_001724.4). PP2 spans the nonsense mutation
(forward primer 50-TGGACCTAAGGACTCGATATAC-30 nucleotides
3,332–3,353; reverse primer 50-TCCTCTACTCGGGACTTTTG-30
nucleotides 3,584–3,565; PCR product size 253 bp). PP3 is sited in
the 30 untranslated region (forward primer 50-CTTCAGAACTCCCCT
TCATTG-30 nucleotides 8,371–8,391; reverse primer 50-GAAATGG
GACATTGTGGTAAAC-30 nucleotides 8,601–8,580; PCR product
size 236 bp). The annealing temperature was 55 1C for all reactions.
Real-time quantitative PCR was carried out using an ABI Prism 700
Instrument (Applied Biosystems) and SYBR Green PCR Master Mix
(Applied Biosystems), following the manufacturer’s recommen-
dations. Briefly, 1ml of cDNA solution was used in 10 ml PCR
containing 1 SYBR Green I master mix with 2.5mM of MgCl2 and
primers. Each sample was run in duplicate, and each PCR run
included a no-template control. The 18S ribosomal RNA expression
was used as internal reference for relative quantification.
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